Stocklytics Platform
HROW
Harrow Health, Inc. - 11.875% Senior Notes due 2027
HROWM4
$26.40arrow_drop_up0.72%$0.18
HROW
HROWM4

$26.40

arrow_drop_up0.72%

Performance History

Chart placeholder
Key Stats
Open$26.21
Prev. Close$26.21
EPS-
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range26.21
26.65
52 Week Range22.71
27.72
Ratios
P/B Ratio-
Revenue-
Operating M. %-
Earnings-
Earnings Growth %-
EBITDA Margin %-
ROE %-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM)

The Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) is a financial instrument issued by Harrow Health, Inc. These senior notes have a maturity date of 2027 and carry an 11.875% interest rate. They are a form of debt that Harrow Health, Inc. has issued to raise capital for its operations. Investors who buy these notes are essentially lending money to the company and will receive interest payments until the notes mature.
Harrow Health, Inc. (HROWM) is a pharmaceutical company that specializes in developing and commercializing innovative treatments for various medical conditions. The company is committed to improving patient outcomes and delivering value to its shareholders. The 11.875% Senior Notes due 2027 are just one example of how Harrow Health, Inc. is financing its operations and growth.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add Harrow Health, Inc. - 11.875% Senior Notes due 2027 to watchlist

Keep an eye on Harrow Health, Inc. - 11.875% Senior Notes due 2027

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the 52-week high and low for Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM)?

For Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM), the 52-week high is $27.72, which is 5% from the current price. The 52-week low is $22.71, the current price is 16.25% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) a growth stock?

Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) has shown an average price growth of -7.23% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Harrow Health, Inc. - 11.875% Senior Notes due 2027 as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Harrow Health, Inc. - 11.875% Senior Notes due 2027's (HROWM) price per share?

The current price per share for Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) is $26.4. The stock has seen a price change of $0.19 recently, indicating a 0.72% change. This reflects the stock's recent market performance and investor sentiment.
help

What is Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) stock price performance year to date (YTD)?

As of the latest data, Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) has a year-to-date price change of 2.13%. Over the past month, the stock has experienced a price change of 0.38%. Over the last three months, the change has been -0.19%. Over the past six months, the figure is -0.92%.
help

Is Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) a profitable company?

Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) has a net income of , which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Furthermore, the EBITDA is $500.78M.
help

What is the market capitalization of Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM)?

Harrow Health, Inc. - 11.875% Senior Notes due 2027 (HROWM) has a market capitalization of $2.26B. The average daily trading volume is 26.4, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level